These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 9126677)

  • 41. Nisoldipine CC: clinical experience in ischaemic heart disease.
    Melcher A; Dens J; Curry P; Hagel H
    Cardiology; 1997; 88 Suppl 1():17-23; discussion 24-5. PubMed ID: 9118164
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of nisoldipine on exercise performance in heart failure following myocardial infarction.
    Lewis BS; Makhoul N; Merdler A; Flugelman MY; Front A; Hardoff R; Halon DA
    Cardiology; 1991; 79(1):39-45. PubMed ID: 1777913
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Nisoldipine CC: clinical experience in hypertension.
    Langan J; Rodríguez-Mañas L; Sareli P; Heinig R
    Cardiology; 1997; 88 Suppl 1():56-62; discussion 63-5. PubMed ID: 9118169
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Myocardial effects of the calcium antagonists nifedipine, nisoldipine and isradipine in coronary heart disease].
    Mauser M; Voelker W; Ickrath O; Kühlkamp V; Karsch KR
    Dtsch Med Wochenschr; 1990 May; 115(19):723-9. PubMed ID: 2140095
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A study to investigate the comparative efficacy and tolerability of nisoldipine coat-core and atenolol in the treatment of mild to moderate hypertension.
    Murray TS
    Br J Clin Pract; 1996; 50(7):368-72. PubMed ID: 9015908
    [TBL] [Abstract][Full Text] [Related]  

  • 46. What does nisoldipine coat core (CC) add to current therapy that is clinically meaningful?
    Opie LH
    Am J Cardiol; 1997 May; 79(10A):29-32; discussion 47-8. PubMed ID: 9186064
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Nisoldipine attenuates myocardial stunning induced by multiple coronary occlusions in conscious pigs and this effect is independent of changes in hemodynamics or coronary blood flow.
    Park SW; Tang XL; Qiu Y; Sun JZ; Bolli R
    J Mol Cell Cardiol; 1996 Apr; 28(4):655-66. PubMed ID: 8732494
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Rapid-release and coat-core formulations of nisoldipine in treatment of hypertension, angina, and heart failure.
    Hamilton SF; Houle LM; Thadani U
    Heart Dis; 1999; 1(5):279-88. PubMed ID: 11720635
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Long term effects of nisoldipine on the progression of coronary atherosclerosis and the occurrence of clinical events: the NICOLE study.
    Dens JA; Desmet WJ; Coussement P; De Scheerder IK; Kostopoulos K; Kerdsinchai P; Supanantaroek C; Piessens JH
    Heart; 2003 Aug; 89(8):887-92. PubMed ID: 12860866
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Improvement of postinfarct left myocardial contractile function after administration of diltiazem].
    Gambelli G; Donati R; Mezzanotte R; Pozzar F; Cesario AS; Schiavo B; Pau F
    G Ital Cardiol; 1998 Mar; 28(3):249-58. PubMed ID: 9561879
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hemodynamic effects of nisoldipine, a highly specific calcium antagonist, in patients with acute myocardial infarction.
    Wilson J; Commerford PJ; Millar RS; Opie LH
    Cardiovasc Drugs Ther; 1992 Feb; 6(1):41-6. PubMed ID: 1576095
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Angiotensin-converting enzyme inhibitors and calcium antagonists after acute myocardial infarction.
    Poole-Wilson PA
    Am J Cardiol; 1995 Apr; 75(13):4E-9E. PubMed ID: 7726123
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Calcium-channel blockers for hypertension--uncertainty continues.
    Cutler JA
    N Engl J Med; 1998 Mar; 338(10):679-81. PubMed ID: 9486999
    [No Abstract]   [Full Text] [Related]  

  • 54. Dynamic stress echocardiography for evaluating anti-ischemic drug profiles in post-MI patients.
    Nixdorff U; Erbel R; Wagner S; Buck T; Mertes H; Mohr-Kahaly S; Meyer J
    Int J Card Imaging; 1997 Dec; 13(6):485-91. PubMed ID: 9415850
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Nisoldipine coat-core and heart rate response during treatment of hypertension.
    Zannad F
    Int J Clin Pract; 1999; 53(1):65-71. PubMed ID: 10344070
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Stress echocardiography--a new test for evaluating the anti-ischemic effect of medication].
    Leischik R; Adamczewski O; Pötter S; Erbel R; Lösse B
    Z Kardiol; 1995 Aug; 84(8):621-32. PubMed ID: 7571769
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The effect of nisoldipine on renal function in the long-term treatment of hypertension in patients with and without renal impairment.
    Wilson J; Wahbha MM; Martin PG; Hainsworth R; Brownjohn AM; Turney JH; Davies JA; Prentice CR
    Eur J Clin Pharmacol; 1989; 37(5):437-41. PubMed ID: 2689184
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Controlled double blind trial of nisoldipine in the treatment of idiopathic Raynaud's phenomenon.
    Gjørup T; Hartling OJ; Kelbaek H; Nielsen SL
    Eur J Clin Pharmacol; 1986; 31(4):387-9. PubMed ID: 3816916
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Usefulness of Nisoldipine for prevention of restenosis after percutaneous transluminal coronary angioplasty (results of the NICOLE study). NIsoldipine in COronary artery disease in LEuven.
    Dens JA; Desmet WJ; Coussement P; De Scheerder IK; Kostopoulos K; Kerdsinchai P; Supanantaroek C; Piessens JH
    Am J Cardiol; 2001 Jan; 87(1):28-33. PubMed ID: 11137829
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Antihypertensive treatment and CHD in the elderly.
    Fink KS; Ellsworth A
    Am Fam Physician; 1999 Sep; 60(4):1102, 1104, 1107. PubMed ID: 10507742
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.